1 completed. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
Follow RDEA3170 4.5 mg: new trials by email Literature Review of RDEA3170 4.5 mg trials Research Report on RDEA3170 4.5 mg
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| RDEA3170 PK/PD Study RDEA3170 4.5 mg, RDEA3170 6 mg, RDEA3170 12 mg - Gout | Phase 1 | Completed | Ardea Biosciences, Inc. | 40 | 2015-11-01 | 2016-09-02 |
Gout (1)
United States (1)
J. Hall, MD (1)